Catherine C. Coombs, MD, UNC School of Medicine
Advertisement
Articles by Catherine C. Coombs, MD, UNC School of Medicine
Catherine Callaghan Coombs, MD, discusses the efficacy results of the ongoing phase 1/2 BRUIN study with pirtobrutinib in chronic lymphocytic leukemia.
Advertisement
Latest Updated Articles
Therapeutic Sequencing in Relapsed/Refractory CLLJanuary 8th 2021
Allogeneic Transplantation for CLLJanuary 8th 2021
Frontline CLL Treatment: Addressing Unmet NeedsJanuary 8th 2021
Selecting Frontline Therapy to Treat CLLJanuary 8th 2021
Frontline CLL Treatment With Fixed-Duration RegimensJanuary 8th 2021
Minimal Residual Disease in CLLJanuary 8th 2021
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
2
Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC
3
Novel Analysis Reveals Millions of Life-Years Saved by Blood Cancer Treatments
4
Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC
5